Kwong Lung Enterprise Yönetim

Yönetim kriter kontrolleri 3/4

Kwong Lung Enterprise CEO'su Ho-Po Chan, Jan2012 tarihinde atandı, in görev süresi 12.83 yıldır. şirketin hisselerinin 2.09% doğrudan sahiptir ve bu hisselerin değeri NT$ 178.65M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4 yıl ve 8.4 yıldır.

Anahtar bilgiler

Ho-Po Chan

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	12.8yrs
CEO sahipliği	2.1%
Yönetim ortalama görev süresi	4yrs
Yönetim Kurulu ortalama görev süresi	8.4yrs

Son yönetim güncellemeleri

Recent updates

Kwong Lung Enterprise (GTSM:8916) Will Be Hoping To Turn Its Returns On Capital Around

Apr 02

Are Dividend Investors Making A Mistake With Kwong Lung Enterprise Co., Ltd. (GTSM:8916)?

Feb 25

Kwong Lung Enterprise (GTSM:8916) Seems To Use Debt Quite Sensibly

Jan 22

We're Watching These Trends At Kwong Lung Enterprise (GTSM:8916)

Dec 31

Kwong Lung Enterprise Co., Ltd. (GTSM:8916) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Dec 17

How Much Is Kwong Lung Enterprise Co., Ltd. (GTSM:8916) CEO Getting Paid?

Nov 25

CEO Tazminat Analizi

Ho-Po Chan'un ücretlendirmesi Kwong Lung Enterprise'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	NT$548m
Jun 30 2024	n/a	n/a	NT$624m
Mar 31 2024	n/a	n/a	NT$647m
Dec 31 2023	n/a	n/a	NT$575m
Sep 30 2023	n/a	n/a	NT$670m
Jun 30 2023	n/a	n/a	NT$824m
Mar 31 2023	n/a	n/a	NT$803m
Dec 31 2022	n/a	n/a	NT$874m
Sep 30 2022	n/a	n/a	NT$1b
Jun 30 2022	n/a	n/a	NT$604m
Mar 31 2022	n/a	n/a	NT$487m
Dec 31 2021	NT$19m	NT$8m	NT$470m
Sep 30 2021	n/a	n/a	NT$239m
Jun 30 2021	n/a	n/a	NT$401m
Mar 31 2021	n/a	n/a	NT$405m
Dec 31 2020	NT$18m	NT$12m	NT$299m
Sep 30 2020	n/a	n/a	NT$303m
Jun 30 2020	n/a	n/a	NT$405m
Mar 31 2020	n/a	n/a	NT$498m
Dec 31 2019	NT$18m	NT$13m	NT$486m
Sep 30 2019	n/a	n/a	NT$633m
Jun 30 2019	n/a	n/a	NT$634m
Mar 31 2019	n/a	n/a	NT$557m
Dec 31 2018	NT$17m	NT$12m	NT$618m

Tazminat ve Piyasa: Ho-Po şirketinin toplam tazminatının TW pazarındaki benzer büyüklükteki şirketlerle karşılaştırıldığında makul olup olmadığını tespit etmek için yeterli veri yok.

Tazminat ve Kazançlar: Ho-Po 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Ho-Po Chan

12.8yrs

Görev süresi

NT$18,839,000

Tazminat

Mr. Ho-Po Chan has been Chairman and Chief Executive Officer of Kwong Lung Enterprise Co., Ltd since June 21, 2016 and has been its Director since June 15, 2007 and also serves as its General Manager of Ga...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Qiu-Yue Zheng	Vice General Manager	no data	NT$8.18m	Veri yok
Li-Ting Hsu	Vice General Manager	no data	NT$5.71m	0.26% NT$ 22.3m
Yi-Fan Ren	Vice General Manager	no data	NT$6.84m	0.32% NT$ 27.5m
Jui-Wen Wang	Vice General Manager	no data	NT$4.02m	Veri yok
Ho-Po Chan	Chairman	12.8yrs	NT$18.84m	2.09% NT$ 178.7m
Jung-Hua Chang	Chief Financial Officer	4yrs	Veri yok	Veri yok
Sung Sherry	Accounting Officer	3.1yrs	Veri yok	Veri yok

4.0yrs

Ortalama Görev Süresi

Deneyimli Yönetim: 8916 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Ho-Po Chan	Chairman	17.4yrs	NT$18.84m	2.09% NT$ 178.7m
Fu-Ju Chan	Representative Director	8.4yrs	NT$3.18m	Veri yok
Chen-Yun Chang	Director	8.4yrs	NT$1.85m	0.40% NT$ 34.5m
Chi-Che Chan	Supervisor	7.9yrs	NT$872.00k	Veri yok
Chao-Fu Li	Vice Chairman	3.6yrs	NT$5.27m	0.19% NT$ 16.0m
Hsien-Yeh Chen	Independent Director	8.4yrs	NT$3.61m	Veri yok
Hsun-Hsiung Tsai	Independent Director	8.4yrs	NT$2.83m	0.28% NT$ 24.0m
Chia-Te Hsu	Independent Director	2.8yrs	Veri yok	Veri yok
Tsui-Ting Ko	Independent Director	2.8yrs	NT$2.11m	Veri yok

8.4yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: 8916 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.4 yıldır).

Kwong Lung Enterprise Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Kwong Lung Enterprise Co., Ltd., Annual General Meeting, May 31, 2024

Kwong Lung Enterprise Co., Ltd.'S Board of Directors Resolves to Establish A Risk Management Committee

Kwong Lung Enterprise Co., Ltd. Announces Change of Corporate Governance Officer

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: NT$0.91 (vs NT$1.44 in 3Q 2023)

Second quarter 2024 earnings released: EPS: NT$1.64 (vs NT$1.87 in 2Q 2023)

Now 21% overvalued

Kwong Lung Enterprise Co., Ltd. to Report Q2, 2024 Results on Aug 08, 2024

Upcoming dividend of NT$3.58 per share

Kwong Lung Enterprise Co., Ltd. Approves Cash Dividend on Common Shares, Payable on August 21, 2024

First quarter 2024 earnings released: EPS: NT$0.98 (vs NT$0.53 in 1Q 2023)

New minor risk - Shareholder dilution

Kwong Lung Enterprise Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

Full year 2023 earnings released: EPS: NT$3.93 (vs NT$6.54 in FY 2022)

Kwong Lung Enterprise Co., Ltd., Annual General Meeting, May 31, 2024

Kwong Lung Enterprise Co., Ltd.'S Board of Directors Resolves to Establish A Risk Management Committee

Third quarter 2023 earnings released: EPS: NT$1.44 (vs NT$2.78 in 3Q 2022)

Kwong Lung Enterprise Co., Ltd. Announces Change of Corporate Governance Officer

New minor risk - Shareholder dilution

Second quarter 2023 earnings released: EPS: NT$1.68 (vs NT$1.89 in 2Q 2022)

Upcoming dividend of NT$3.79 per share at 7.2% yield

Price target decreased by 11% to NT$62.00

Kwong Lung Enterprise Co., Ltd. Approves Dividend on Common Share, Payable on August 31, 2023

Full year 2022 earnings released: EPS: NT$6.54 (vs NT$3.58 in FY 2021)

Price target increased to NT$67.00

Third quarter 2022 earnings released: EPS: NT$2.78 (vs NT$0.26 loss in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: NT$1.89 (vs NT$1.00 in 2Q 2021)

Upcoming dividend of NT$3.00 per share

Kwong Lung Enterprise Co., Ltd. Announces Common Share Cash Dividend, Payable on August 19, 2022

First quarter 2022 earnings released: EPS: NT$1.11 (vs NT$0.98 in 1Q 2021)

Less than half of directors are independent

Full year 2021 earnings released: EPS: NT$3.58 (vs NT$2.28 in FY 2020)

Third quarter 2021 earnings released: NT$0.26 loss per share (vs NT$0.98 profit in 3Q 2020)

Price target decreased to NT$40.00

Less than half of directors are independent

Less than half of directors are independent

First quarter 2021 earnings released: EPS NT$0.98 (vs NT$0.17 in 1Q 2020)

Representative Director has left the company

Full year 2020 earnings released: EPS NT$2.28 (vs NT$4.10 in FY 2019)

Kwong Lung Enterprise (GTSM:8916) Will Be Hoping To Turn Its Returns On Capital Around

Full year 2020 earnings released: EPS NT$2.28 (vs NT$4.10 in FY 2019)

Kwong Lung Enterprise Co., Ltd., Annual General Meeting, May 31, 2021

New 90-day high: NT$40.35

Are Dividend Investors Making A Mistake With Kwong Lung Enterprise Co., Ltd. (GTSM:8916)?

Kwong Lung Enterprise (GTSM:8916) Seems To Use Debt Quite Sensibly

New 90-day low: NT$38.50

We're Watching These Trends At Kwong Lung Enterprise (GTSM:8916)

Kwong Lung Enterprise Co., Ltd. (GTSM:8916) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

New 90-day low: NT$39.25

How Much Is Kwong Lung Enterprise Co., Ltd. (GTSM:8916) CEO Getting Paid?

Kwong Lung Enterprise Announces Executive Changes, Effective November 09, 2020

Third quarter 2020 earnings released: EPS NT$0.98

Revenue misses expectations

New 90-day low - NT$40.30

First half earnings released

First half earnings released

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi